← Back to Search

Antimicrobial Stewardship Intervention

Antimicrobial stewardship prospective audit and feedback for Coronavirus (COVASP Trial)

N/A

Waitlist Available

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 days

Awards & highlights

COVASP Trial Summary

This trial will compare the effect of an antimicrobial stewardship intervention (prospective audit and feedback) versus no intervention on clinical outcomes in patients hospitalized with acute COVID-19.

Eligible Conditions

Coronavirus
Coronavirus Pneumonia
Coronavirus Lower Respiratory Infection
COVID-19

COVASP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Ordinal scale

Secondary outcome measures

30 day re-admission rate

30-day C. difficile associated mortality

30-day mortality

+11 more

COVASP Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Antimicrobial stewardshipExperimental Treatment1 Intervention

Antimicrobial stewardship prospective audit and feedback on physicians attending to patients admitted with community-acquired COVID-19 pneumonia to beds randomized to antimicrobial stewardship intervention.

Group II: No antimicrobial stewardshipActive Control1 Intervention

No antimicrobial stewardship prospective audit and feedback.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Antimicrobial stewardship prospective audit and feedback

2021

N/A

~840

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

888 Previous Clinical Trials

384,125 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open opportunities to join this research experiment?

"According to clinicaltrials.gov, this specific medical trial is not presently enrolling individuals (first posted on March 1 2021 and last updated May 10 2022). However, there are many other trials that are currently accepting patients; 1988 in total!"

Answered by AI

Recent research and studies

American Journal of Respiratory and Critical Care MedicineJournal

COVID-19 with Different Severities: A Multicenter Study of Clinical Features

Feng, Yun, Yun Ling, Tao Bai, Yusang Xie, Jie Huang, Jian Li, Weining Xiong, et al.. 2020. “COVID-19 with Different Severities: A Multicenter Study of Clinical Features”. American Journal of Respiratory and Critical Care Medicine. American Thoracic Society. doi:10.1164/rccm.202002-0445oc.

The Lancet Infectious DiseasesJournal

An Interactive Web-based Dashboard to Track COVID-19 in Real Time

Dong, Ensheng, Hongru Du, and Lauren Gardner. 2020. “An Interactive Web-based Dashboard to Track COVID-19 in Real Time”. The Lancet Infectious Diseases. Elsevier BV. doi:10.1016/s1473-3099(20)30120-1.

Infection Control & Hospital EpidemiologyJournal

Involving Antimicrobial Stewardship Programs in COVID-19 Response Efforts: All Hands on Deck

Stevens, Michael P., Payal K. Patel, and Priya Nori. 2020. “Involving Antimicrobial Stewardship Programs in COVID-19 Response Efforts: All Hands on Deck”. Infection Control & Hospital Epidemiology. Cambridge University Press (CUP). doi:10.1017/ice.2020.69.

Clinical Infectious DiseasesJournal